Literature DB >> 2571641

Melanogenic regulatory factors in coated vesicles from melanoma cells.

A K Chakraborty1, Y Mishima, M Inazu, S Hatta, M Ichihashi.   

Abstract

Coated vesicles have been found to contain much higher tyrosinase and gamma-glutamyl transpeptidase activities than premelanosomes. This indicates that similar to tyrosinase, gamma-glutamyl transpeptidase, an enzyme responsible for pheomelanogenesis, is highly concentrated in coated vesicles after its maturation in Golgi associated endoplasmic reticulum (GERL). Furthermore, in the pre- and post-dopaquinone melanogenic pathway, coated vesicles convert dopachrome to colorless indole compounds more quickly than in premelanosomes because of their higher dopachrome conversion factor activity. Melanosomes have been found to exhibit indole conversion factor activity, while coated vesicles show indole blocking factor activity. In moderately tyrosinase-rich premelanosomes, the levels of dopachrome conversion factor and indole blocking factor are lower than in coated vesicles or melanosomes. High levels of indole blocking factor in coated vesicles may indicate why melanin polymer formation does not occur there in vivo despite their high tyrosinase activity.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2571641     DOI: 10.1111/1523-1747.ep12319736

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  3 in total

1.  The action of glycosylases on dopachrome (2-carboxy-2,3-dihydroindole-5,6-quinone) tautomerase.

Authors:  P Aroca; J H Martinez-Liarte; F Solano; J C García-Borrón; J A Lozano
Journal:  Biochem J       Date:  1992-05-15       Impact factor: 3.857

2.  AP-3 mediates tyrosinase but not TRP-1 trafficking in human melanocytes.

Authors:  M Huizing; R Sarangarajan; E Strovel; Y Zhao; W A Gahl; R E Boissy
Journal:  Mol Biol Cell       Date:  2001-07       Impact factor: 4.138

3.  5,6-Dihydroxyindole-2-carboxylic acid is incorporated in mammalian melanin.

Authors:  K Tsukamoto; A Palumbo; M D'Ischia; V J Hearing; G Prota
Journal:  Biochem J       Date:  1992-09-01       Impact factor: 3.857

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.